The 9 most recent market catalysts affecting $VTR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 15, 2026
Corporate Catalyst
Neutral
Impact 55
Jefferies Assumes Ventas at Buy, Announces Price Target of $102
Jefferies analyst Joe Dickstein has assumed coverage of Ventas (VTR) with a 'Buy' rating and a price target of $102. This is a positive development for Ventas as it indicates a pro…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 55
Scotiabank Maintains Sector Perform on Ventas, Raises Price Target to $95
Scotiabank analyst Nicholas Yulico maintained a 'Sector Perform' rating on Ventas (VTR) but raised the price target from $93 to $95. This indicates a slightly improved valuation pe…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Overweight on Ventas, Raises Price Target to $104
Wells Fargo analyst John Kilichowski has maintained an 'Overweight' rating on Ventas (VTR) and raised the price target from $96 to $104. This action signals continued confidence fr…
Aug 31, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Equal-Weight on Ventas, Raises Price Target to $102
Barclays analyst Richard Hightower maintained an 'Equal-Weight' rating on Ventas (VTR) but raised the price target from $99 to $102. This indicates a minor positive adjustment in t…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 55
BMO Capital Maintains Outperform on Ventas, Raises Price Target to $107
BMO Capital analyst John Kim maintained an 'Outperform' rating on Ventas (VTR) and raised the price target from $105 to $107. This action signals continued confidence from a promin…
Jul 31, 2026
Market Technicals
Bullish
Impact 55
Cantor Fitzgerald Maintains Overweight on Ventas, Raises Price Target to $102
Cantor Fitzgerald analyst Richard Anderson has maintained an 'Overweight' rating on Ventas and raised the price target from $97 to $102. This action signals a continued bullish sen…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 75
Ventas Raises FY2026 FFO Guidance from $3.82-$3.89 to $3.85-$3.90 vs $3.85 Est
Ventas, a healthcare real estate investment trust (REIT), has raised its FY2026 FFO guidance from $3.82-$3.89 to $3.85-$3.90. This is a significant development as the new lower bou…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 92
Ventas Q2 FFO $0.97 Beats $0.95 Estimate, Sales $1.730B Beat $1.680B Estimate
Ventas (VTR) announced Q2 earnings that surpassed analyst estimates on both FFO per share and revenue. FFO of $0.97 beat the $0.95 consensus, and sales of $1.730 billion exceeded t…
Jul 22, 2026
Corporate Catalyst
Bullish
Impact 55
Mizuho Maintains Outperform on Ventas, Raises Price Target to $104
Mizuho analyst Vikram Malhorta maintained an Outperform rating on Ventas (VTR) and raised the price target from $98 to $104. This analyst action signals continued confidence in Ven…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.